Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.06
-0.84 (-4.02%)
Apr 17, 2026, 3:15 PM HKT
Market Cap9.55B
Revenue (ttm)146.34M
Net Income-379.87M
EPS-0.88
Shares Out456.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume950,800
Average Volume1,087,210
Open20.94
Previous Close20.90
Day's Range19.92 - 20.94
52-Week Range19.05 - 74.00
Betan/a
RSI42.86
Earnings DateMar 23, 2026

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 193
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements